# Hyperammonemic Encephalopathy and Thyroid Storm Leading to Coma: A Case Report

**Authors:** Tung Phi Nguyen, Thang Trong Khong, Tuan Duc Tran

PMC · DOI: 10.1155/crcc/2330763 · Case Reports in Critical Care · 2025-07-03

## TL;DR

A 33-year-old man developed coma from hyperammonemic encephalopathy and thyroid storm, showing how these rare conditions can occur together without liver issues.

## Contribution

This case report presents a rare co-occurrence of hyperammonemic encephalopathy and thyroid storm without hepatic dysfunction.

## Key findings

- The patient showed rapid neurological decline with hyperammonemia and thyrotoxicosis.
- Treatment with propylthiouracil, iodine, propranolol, hydrocortisone, and CRRT led to ammonia reduction and recovery.
- The case suggests a possible but unconfirmed link between thyroid dysfunction and ammonia metabolism.

## Abstract

Hyperammonemic encephalopathy is a rare but serious condition often linked to hepatic dysfunction or metabolic disorders. Thyroid storm is an endocrine emergency that can cause profound metabolic disturbances, though its relationship with hyperammonemia remains unclear. We report a unique case of a 33-year-old previously healthy male who developed progressive fatigue, nausea, and vomiting, followed by acute neurological deterioration. Initial evaluation revealed hyperammonemia (284 μmol/L) and thyrotoxicosis (fT4: 27 pmol/L and TSH: 0.007 μIU/mL), with no hepatic dysfunction. His neurological status declined from GCS 12 to GCS 7 within hours. Brain MRI and cerebrospinal fluid analysis were unremarkable. The patient was diagnosed with coma in the setting of hyperammonemic encephalopathy and thyroid storm. Management included propylthiouracil, Lugol's iodine, propranolol, hydrocortisone, and continuous renal replacement therapy (CRRT). His ammonia levels significantly improved within 48 h, leading to rapid clinical improvement and extubation. This case highlights the importance of recognizing hyperammonemia as a potential cause of altered mental status, even in the absence of hepatic dysfunction, and raises questions about potential but unestablished links between thyroid dysfunction and ammonia metabolism.

## Linked entities

- **Chemicals:** propylthiouracil (PubChem CID 657298), Lugol's iodine (PubChem CID 105053), propranolol (PubChem CID 4946), hydrocortisone (PubChem CID 5754)
- **Diseases:** thyroid storm (MONDO:0006996)

## Full-text entities

- **Diseases:** hepatic dysfunction (MESH:D008107), Hyperammonemic Encephalopathy (MESH:D001927), Thyroid Storm (MESH:D013958), metabolic disorders (MESH:D008659), neurological deterioration (MESH:D009422), hyperammonemia (MESH:D022124), thyrotoxicosis (MESH:C566386), thyroid dysfunction (MESH:D013959), nausea (MESH:D009325), fatigue (MESH:D005221), vomiting (MESH:D014839), Coma (MESH:D003128)
- **Chemicals:** propylthiouracil (MESH:D011441), ammonia (MESH:D000641), hydrocortisone (MESH:D006854), propranolol (MESH:D011433), Lugol's iodine (MESH:C010389)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12245493/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12245493/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12245493/full.md

---
Source: https://tomesphere.com/paper/PMC12245493